Latest / The Buyout Show with Fexingo: Private Equity, Roll-Ups, and Business Acquisitions / The Silent Roll-Up of Independent Veterinary Clinics
Transcript
- Lucas: If these conversations have moved your work forward in some small way, I want to mention that a handful of listeners chip in monthly through buy me a coffee dot com slash fexingo, and that's literally what funds making this many of these episodes without ads. Luna: Yeah, it keeps the lights on and the research sharp. Thanks for supporting us. Lucas: Let's jump right in. You take your dog to the vet. The receptionist smiles, the exam happens, and you pay. But who actually owns that building? Who sets the price for the rabies shot? For years, the answer was Dr. Smith or Dr. Jones. Today, the answer is increasingly a limited partnership in Delaware. Luna: I noticed this when my cat needed surgery last year. The billing code didn't match the independent clinic I used five years ago. It felt corporate, but cheaper per unit. Lucas: That feeling is the signal. The veterinary industry has historically been one of the most fragmented sectors in America. Roughly ninety percent of practices were independently owned as recently as two thousand and fifteen. That number has shifted dramatically because private equity firms realized that medicine is sticky. People don't switch vets easily, and pets age, meaning lifetime value is high and predictable. Luna: So they aren't buying land; they're buying recurring revenue streams attached to living creatures. Lucas: Exactly. And the mechanism is the roll-up. You start with a platform company, maybe a regional group of ten clinics, and then you use debt-fueled acquisitions to bolt on smaller competitors. The goal isn't just growth; it's margin expansion through shared services. One HR department, one central purchasing arm, one marketing budget for all fifty locations instead of fifty separate ones. Luna: It reminds me of how big box stores squeezed local hardware shops, but here the product is specialized medical care. Lucas: The comparison holds, but the barrier to entry is higher. You can open a retail store in a weekend. You need board-certified specialists to run a surgical suite. That scarcity of talent is actually part of the playbook. Private equity groups often hire non-clinical operators to manage the business side while letting the veterinarians focus on patients. It separates ownership from practice. Luna: Does that separation create friction? Do vets feel like employees rather than partners? Lucas: It creates a fundamental tension. In the traditional model, the vet-owner bears the risk and reaps the reward. In the PE model, the veterinarian becomes a highly compensated employee with production quotas. If you miss your quarterly targets, you don't lose the deed to the building, but you might lose your bonus. The incentive structure shifts from long-term asset building to short-term volume optimization. Luna: Volume optimization sounds efficient until you realize it might mean recommending unnecessary procedures. Lucas: That is the ethical concern driving much of the backlash. Critics argue that standardized protocols and upselling incentives compromise clinical judgment. However, proponents point out that large networks can invest in advanced imaging equipment, like MRI machines, that an independent clinic simply cannot afford. So you get a trade-off: potential conflict of interest versus access to higher-tier technology. Luna: It’s a classic efficiency versus quality debate. Where do we see the biggest concentration right now? Lucas: Initially, it was the coast to coast giants like VCA and Banfield dominating urban corridors. But by late twenty twenty-three, the playbook had expanded into suburban and even rural markets. Firms started acquiring smaller regional players who had strong local brand loyalty but lacked capital for expansion. This forced the independent vets who stayed solo to compete against well-funded conglomerates. Luna: So the independents got squeezed from above by the giants and from below by the roll-ups? Lucas: Precisely. And many chose to sell. The average sale price for a veterinary practice has nearly doubled over the last decade. When you can retire with a payout that exceeds twenty years of profit, the temptation to exit is massive. This creates a self-reinforcing cycle where more sellers enter the market, driving valuations up, which attracts more capital, which buys more clinics. Luna: What about the supply chain? I imagine buying syringes in bulk makes a huge difference. Lucas: It does. Centralized procurement allows these groups to negotiate steep discounts on pharmaceuticals, implants, and diagnostic kits. Some estimates suggest a consolidated network can reduce supply costs by fifteen to twenty percent compared to independent buyers. Those savings flow directly to the bottom line, allowing for lower prices or higher margins depending on competitive pressure. Luna: Do consumers actually see lower prices, or do the companies just keep the extra margin? Lucas: Usually both. Prices have risen, but not as fast as inflation in other healthcare sectors. However, the margin improvement is real. Private equity firms typically target internal rates of return above twenty percent. They achieve this by squeezing operational waste, optimizing staff ratios, and leveraging financial engineering. The debt used to buy these clinics becomes a burden on the cash flow of the individual practices. Luna: Debt-loaded clinics sound risky if client traffic drops. What happens during an economic downturn? Lucas: This is the critical stress test. Pet spending is generally resilient, but it is not immune. During periods of high inflation, owners may delay elective surgeries or choose generic medications over branded ones. If revenue dips while debt service remains fixed, the leverage becomes dangerous. We saw early signs of this strain in twenty twenty-four, with some portfolio companies struggling to meet covenant requirements. Luna: So the model works best in stable times, but volatility exposes the fragility. Lucas: Correct. And there is another layer: the talent shortage. Veterinarians are burning out at unprecedented rates. High student debt, emotional fatigue, and long hours drive many out of the profession. Consolidated firms try to mitigate this with better benefits and scheduled shifts, but turnover remains a structural headwind. You cannot roll up a business if you cannot find enough doctors to run the clinics. Luna: Is there a limit to how many clinics one firm can own before the brand dilutes? Lucas: There is. Brand trust is everything in veterinary medicine. If a consumer feels their local vet has become a faceless corporation, they leave. Successful roll-ups maintain a veneer of independence. They keep local names on the door, hire local managers, and emphasize community ties. It is psychological branding as much as physical presence. Luna: It’s subtle manipulation of perception. Like owning a boutique hotel chain but keeping the original innkeeper as a mascot. Lucas: That is a very accurate analogy. The owner changes, but the story sells. Now, looking ahead to the rest of twenty twenty-six, the question is whether regulatory scrutiny will increase. Antitrust authorities are watching healthcare consolidation closely. While veterinary services are not currently considered essential infrastructure in the same way as hospitals, the sheer volume of capital entering the space raises eyebrows. Luna: Will regulators try to block specific deals, or just monitor the trend? Lucas: Mostly monitoring. Breaking up a deal requires proving harm to competition, which is difficult when the market is so fragmented. However, we might see stricter rules on data usage. These firms collect vast amounts of patient data. How that information is monetized or shared across the network could become a privacy battleground. Luna: Data privacy in pet records. That’s a new frontier I hadn’t considered. Lucas: It is. And it ties back to the core thesis: this isn't just about selling cat food. It is about capturing the entire lifecycle of pet ownership through digital integration, subscription models, and insurance partnerships. The clinic is just the entry point. Luna: So the clinic is the hook, and the ecosystem is the trap. Lucas: Or the convenience feature, depending on your perspective. For investors, the sector offers defensive characteristics. For workers, it offers stability but less upside. For owners, it offers liquidity but less control. Luna: Three different outcomes from the same transaction. Which dynamic do you think will define the next three years? Lucas: The talent war. Whoever solves the retention problem for veterinarians will win the market. Technology alone won't fix burnout. Culture will. If the roll-ups can prove they offer better quality of life than solo practice, they continue expanding. If not, the independent sector finds a niche as the premium, boutique alternative. Luna: A boutique luxury segment for pet care. Does that make sense financially? Lucas: Absolutely. Just as artisanal bakeries survive next to supermarket chains, independent vets can thrive by offering personalized relationships that algorithms cannot replicate. The market is bifurcating. Efficiency on one side, experience on the other. Luna: Efficiency and experience. Two roads diverging in a yellow wood, or rather, a yellow examination table. Lucas: Something like that. The money is moving toward efficiency, but the heart of the industry still beats for experience. Watching how those two forces balance out will tell us a lot about the future of service-based businesses. Luna: It’s a fascinating microcosm of the broader economy. Standardization versus personalization. Lucas: Right. And if you listen closely to your next vet visit, you might hear which side of that argument is winning.